Drug Profile
AADvac 2
Alternative Names: AADvac-2; AAdvac2; Alzheimer's passive vaccine - Axon NeuroscienceLatest Information Update: 05 Sep 2023
Price :
$50
*
At a glance
- Originator Axon Neuroscience
- Developer Axon Neuroscience; LifeArc
- Class Alzheimer vaccines; Monoclonal antibodies
- Mechanism of Action Tau protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Alzheimer's disease
Most Recent Events
- 05 Sep 2023 AADvac 2 is still in preclinical trials for Alzheimer's disease in Slovakia (Axon Neurosciences pipeline, September 2023)
- 15 Jun 2017 MRC Technology is now called LifeArc
- 11 Nov 2015 Preclinical trials in Alzheimer's disease in Slovakia